Compare TLRY & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLRY | KIDS |
|---|---|---|
| Founded | N/A | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.4M | 512.4M |
| IPO Year | 2018 | 2016 |
| Metric | TLRY | KIDS |
|---|---|---|
| Price | $3.91 | $18.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $72.33 | $24.67 |
| AVG Volume (30 Days) | ★ 3.5M | 158.9K |
| Earning Date | 04-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $98,049,000.00 |
| Revenue This Year | $8.79 | $14.07 |
| Revenue Next Year | $19.98 | $11.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 37.95 |
| 52 Week Low | $0.55 | $14.42 |
| 52 Week High | $15.70 | $23.07 |
| Indicator | TLRY | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 22.50 | 45.32 |
| Support Level | $0.77 | $15.66 |
| Resistance Level | $4.85 | $18.75 |
| Average True Range (ATR) | 0.18 | 1.13 |
| MACD | -0.02 | -0.22 |
| Stochastic Oscillator | 3.18 | 18.17 |
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.